Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Clarus to Market Perform

Raymond James Downgrades Clarus to Market Perform

Raymond James analyst Joseph Altobello downgrades Clarus (NASDAQ:CLAR) from Outperform to Market Perform.

byBenzinga Newsdesk

August 18, 2022

1 minute read

Raymond James analyst Joseph Altobello downgrades Clarus (NASDAQ:CLAR) from Outperform to Market Perform.

Evercore ISI Group Downgrades BioCryst Pharmaceuticals to In-Line, Announces $14 Price Target

By Benzinga Newsdesk

August 5, 4:41 AM

Evercore ISI Group analyst Liisa Bayko downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to In-Line and announces $14 price target.

BCRX

$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

By Benzinga Insights

July 27, 3:06 PM

Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 4.3% on an annualized basis producing an average annual return of 11.17%. Currently, Amgen has a market capitalization of $134.51 billion.

AMGN

Analyst Ratings

Analyst Ratings for Vitesse Energy

By Benzinga Insights

June 5, 12:01 PM

Within the last quarter, Vitesse Energy (NYSE:VTS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

VTS

Sam Bankman Fried Is Using A New Currency In Prison To Get Favors From Inmates — Fish

By Mehab Qureshi

November 23, 11:49 PM

In the confines of New York's Metropolitan Detention Center, Sam Bankman-Fried, the former crypto magnate is adapting to the prison’s underground economy.

BTC

Raymond James Downgrades Clarus to Market Perform

Related Posts

Evercore ISI Group Downgrades BioCryst Pharmaceuticals to In-Line, Announces $14 Price Target

$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

Analyst Ratings for Vitesse Energy

Sam Bankman Fried Is Using A New Currency In Prison To Get Favors From Inmates — Fish